50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today BLCM ranks #11064 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Bellicum Pharmaceuticals Stock Forecast NASDAQ:BLCM

$1.84 (0%)

Volume: 74k

Closed: Nov 26, 2021

Hollow Logo Score: -3.588

Bellicum Pharmaceuticals Stock Forecast

$1.84 (0%)

Volume: 74k

Closed: Nov 26, 2021

Score Hollow Logo -3.588

Bellicum Pharmaceuticals Stock Forecast NASDAQ:BLCM

Price Target and Analyst Ratings

Most Recent Rating

Wells Fargo & Company does not see either upside or downside right now giving BLCM "Overweight - Equal Weight" on their last update on Oct 30, 2020. The price target was set to $4.50.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2020-10-30 Buy - Neutral Downgraded by LADENBURG THALM/SH SH $3.71
2020-10-30 Overweight - Equal Weight Downgraded by Wells Fargo & Company $3.71 $4.50

BLCM Stock Trend

The stock lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -43.06% during the next 3 months and, with a 90% probability hold a price between $0.95 and $1.17 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-11-30 $1.64 $1.83 $2.03
2021-12-01 $1.61 $1.81 $2.01
2021-12-02 $1.59 $1.79 $1.98
2021-12-03 $1.56 $1.76 $1.96
2021-12-06 $1.54 $1.74 $1.93
2021-12-07 $1.51 $1.71 $1.91
2021-12-08 $1.49 $1.69 $1.88
2021-12-09 $1.46 $1.66 $1.86
2021-12-10 $1.44 $1.64 $1.84
2021-12-13 $1.41 $1.61 $1.81
2021-12-14 $1.39 $1.59 $1.79
2021-12-15 $1.36 $1.56 $1.76
2021-12-16 $1.34 $1.54 $1.74
2021-12-17 $1.31 $1.51 $1.71
2021-12-20 $1.29 $1.49 $1.69
2021-12-21 $1.27 $1.46 $1.66
2021-12-22 $1.24 $1.44 $1.64
2021-12-23 $1.22 $1.41 $1.61
2021-12-27 $1.19 $1.39 $1.59
2021-12-28 $1.17 $1.37 $1.56
2021-12-29 $1.14 $1.34 $1.54
2021-12-30 $1.12 $1.32 $1.51
2021-12-31 $1.09 $1.29 $1.49
2022-01-03 $1.07 $1.27 $1.46
2022-01-04 $1.04 $1.24 $1.44
2022-01-05 $1.02 $1.22 $1.42
2022-01-06 $0.99 $1.19 $1.39
2022-01-07 $0.97 $1.17 $1.37
2022-01-10 $0.94 $1.14 $1.34
2022-01-11 $0.92 $1.12 $1.32

About Bellicum Pharmaceuticals

Bellicum Pharmaceuticals Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers, solid tumors, and orphan inherited blood disorders in the United States and internationally. Its clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials, administered after allogeneic hematopoietic stem cell trans... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT